Intellia Therapeutics

About:

Intellia Therapeutics is a genome editing company that develops curative gene-editing treatments.

Website: http://intelliatx.com

Twitter/X: intelliatweets

Top Investors: OrbiMed, Fidelity, Novartis, Foresite Capital, Caribou Biosciences

Description:

Intellia Therapeutics is a genome editing company that develops curative gene-editing treatments. It can positively transform the lives of people living with severe and life-threatening diseases. IIntellia holds exclusive access to one of the most comprehensive intellectual property platforms available for the therapeutic use of CRISPR-Cas9. The company is advancing a broad pipeline toward clinical development, including ex Vivo, and in vivo approaches. Intellia Therapeutics was formed in 2014 and is headquartered in Cambridge, Massachusetts.